Development and validation of a quality of life instrument for patients with liver cancer QOL-LC

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 5, 2010, Pages 448-455

  Wan, Chonghua ^a,b   Fang, Jiqian ^c   Yang, Zheng ^a   Zhang, Canzhen ^d   Luo, Jiahong ^a   Meng, Qiong ^a   Jiang, Dan ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d Tumor Hospital of Yunnan Province   (China)

Author keywords

Intraclass correlations; Liver cancer; Quality of life; Standardized response mean; Structural equation model

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; FEMALE; FUNCTIONAL LIVING INDEX CANCER; HUMAN; INTERNAL CONSISTENCY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHYSICAL ACTIVITY; PHYSICAL WELL BEING; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUALITY OF LIFE FOR PATIENTS WITH LIVER CANCER; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SOCIAL ASPECT; SOCIAL WELL BEING; SYMPTOM; TEST RETEST RELIABILITY; WELLBEING; CHINA; FACTORIAL ANALYSIS; LIVER TUMOR; MIDDLE AGED; PSYCHOMETRY; QUESTIONNAIRE; REGRESSION ANALYSIS; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CHINA; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 78049438949     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181b4b04f     Document Type: Article

References (36)

1. Parkin DM, Laara E, Muir CS. Estimates of the world-wide frequency of sixteen major cancers in 1980. Int J Cancer. 1988;41:184-197.
2. Chen JG, Song XM. An evaluation on incidence cases of liver cancer in China [in Chinese]. Bull Chinese Cancer. 2005;14:28-31.
3. Stewart BW, Kleihues P. World Cancer Report. Lyon, France: IARC Press; 2003:1-351.
4. Ferlay J, Bray F, Pisani P. Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARC Press; 2001. IARC Cancer Base No. 5 [DB/CD].
5. El-Sarag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in theUnited States. Hepatology. 2001;33:62-65.
6. Faivre J, Formann D, Esteve J, et al. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer. 1998;34:2184-2190.
7. Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Digest Liver Dis. 2003;35:46-54.
8. Brans B, Lambert B, De Beule E, et al. Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy. Eur J Nucl Med Mol Imaging. 2002;29:1374-1379.
9. Poon RT, Fan ST, Yu WC, et al. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg. 2001;136:693-699.
10. Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002;20:2229-2239.
11. Steel JL, Geller DA, Carr BI. Proxy ratings of health related quality of life in patients with hepatocellular carcinoma. Qual Life Res. 2005;14:1025-1033.
12. Blazeby JM, Currie E, Zee BC, et al. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer. 2004;40: 2439-2444.
13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85: 365-376.
14. Wan CH, Shi ML, Fang JQ. The methods of item-screening in developing quality of life instrument [in Chinese]. J Math Med. 1995;8(suppl):5-8.
15. Schipper H, Clinch J, McMurray A, et al. Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol. 1984;2:472-483.
16. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30-46.
17. Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res. 2004;13:571-586.
18. Terwee CB, Dekker FW, Wiersinga WM, et al. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res. 2003;12:349-363.
19. Husted JA, Cook RJ, Farewell VT, et al. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53:459-468.
20. Bolen KA, Long JS. Testing Structural Equations Models. Newbury Park, CA: Sage; 1993:130-172.
21. Hu LT, Bentler P. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model. 1999;6:1-55.
22. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, eds. Testing Structural Equation Models. Beverly Hills, CA: Sage; 1992:136-162.
23. Wensing M, Vingerhoets E, Grol R. Functional status, health problems, age and comorbidity in primary care patients. Qual Life Res. 2001;10:141-148.
24. Lubetkin EI, Jia H, Gold MR. Use of the SF-36 in Low-income Chinese American primary care patients. Med Care. 2003;41:447-457.
25. The WHOQOL Group. The Word Health Organization Quality of Life assessment (WHOQOL): devolvement and psychometric properties. Soc Sci Med. 1998;46:1569-1585.
26. Wan C, Yang Z, Meng Q, et al. Development and validation of the general module of the system of quality of life instruments for cancer patients (QLICP-GM). Int J Cancer. 2008;122:190-196. (Pubitemid 350209995)
27. Wan C, Lu Y, Tang W, et al. Development and validation of the system of quality of life instruments for cancer patients: lung cancer (QLICP-LU). Lung Cancer. 2008;60:105-112. (Pubitemid 351434462)
28. Wan C. Methodology of Measurement and Assessment of Quality of Life. Kunming, China: Yunnan University Press; 1999:316-326.
29. Presant CA, Klahr C, Hogan L. Evaluating quality of life in oncology patients: pilot observations. Oncol Nurs Forum. 1981;8:26-30.
30. Padilla GV, Presant C, Grant MM, et al. Quality of life index for patients with cancer. Res Nurs Health. 1983;6:117-126.
31. Pfennings L, Cohen L, van der Ploeg H. Preconditions for sensitivity in measuring change: visual analogue scales compared to rating scales in a Likert format. Psychol Reports. 1995;77:475-480.
32. Price DD, Mcgrath PA, Rafil A, et al. The validation of visual analogue scale measures of chronic and experimental pain. Pain. 1983;17:45-56.
33. Zhao JB, Li YH, Chen Y, et al. Evaluation of the quality of life in the patients with primary hepatocellular carcinoma after interventional therapy: a multiple center investigation [in Chinese]. J Clin Radiol. 2002;21:550-552.
34. Zhao JB, Li YH, Chen Y, et al. Evaluation of quality of Life before and after interventional therapy in patients with primary hepatocellular carcinoma [in Chinese]. Chin J Radiol. 2002;36:873-876.
35. Huo JS, Zhang ZJ, Wang CY, et al. The study of curative effects of comprehensive psychological and behavioral intervention in patients with intermediate and advanced liver cancer [in Chinese]. Chin J Behav Med Sci. 2002;11:650-651.
36. Su CR, Zhang J. The impaction and evaluation of the quality of life in the patients with liver cancer for vitriolic morphia control release troche [in Chinese]. Chin J Clines Rehabil. 2003;7:1722.